Summary:
Researchers at the University of Colorado Anschutz have uncovered how herpes simplex virus type 1 (HSV-1), the common virus behind cold sores, fundamentally reprograms the brain’s resident immune cells. Upon infection, microglia pivot into an aggressive, interferon-driven antiviral defense mode while silencing vital homeostatic maintenance genes. These chromatin-level alterations mirror immune signatures seen in Alzheimer’s disease, suggesting that chronic viral exposure may prime the brain for neurodegeneration.
Key Facts:
- Cellular Reprogramming: HSV-1 infection forces microglia to prioritize robust interferon antiviral signaling at the direct expense of their everyday neural maintenance, synaptic pruning, and debris-clearing duties.
- Chromatin Remodeling: The virus does not simply trigger acute inflammation; it alters the accessibility of microglial chromatin, effectively locking in gene expression changes that dictate immune reactivity.
- The Alzheimer’s Connection: The localized microglial state induced by HSV-1 closely mirrors molecular profiles observed in response to aging and established genetic drivers of Alzheimer’s disease, providing a biological link between common viral pathogens and neurodegenerative risk.
Source: University of Colorado Anschutz Medical Campus
Herpes simplex virus type 1 (HSV-1) is best known for causing recurrent cold sores around the mouth, carrying a lifelong presence in more than 60% of the global adult population. While the pathogen typically resides quietly within peripheral nerve ganglia, clinical and epidemiological evidence has increasingly suggested a link between HSV-1 infection, chronic neuroinflammation, and late-onset Alzheimer’s disease.
Yet the biological mechanism through which a common mucosal virus could alter brain health and promote neurodegenerative pathways has remained largely unmapped.
Now, a study led by neuroscientists at the University of Colorado Anschutz Medical Campus reveals that HSV-1 directly re-engineers the brain’s resident immune cells. Publishing in the journal PLOS Pathogens, the researchers showed that the virus triggers enduring epigenetic and transcriptional shifts in microglia, forcing them into a relentless defensive posture that compromises their ability to support normal brain function.
Shifting From Maintenance to Emergency Defense
Microglia function as the central nervous system’s primary caretakers and first responders. Under normal physiological conditions, they continually survey the parenchyma, prune redundant synapses, scavenge metabolic waste, and clear toxic protein aggregates like amyloid-beta.
Using high-resolution single-cell molecular profiling, the research team examined how individual microglia respond when HSV-1 infiltrates neural tissue.
The experiments revealed that exposure to the virus drove microglia into distinct, highly specialized populations dominated by interferon signaling, a potent first-line antiviral cascade. However, this hyper-focused immunological response triggered a steep metabolic trade-off: genes governing basic homeostatic support and tissue maintenance were dramatically downregulated.
“Microglia act as both the brain’s security system and its maintenance crew,” said senior author Christy Niemeyer, PhD, assistant professor of neurology at CU Anschutz. “When HSV-1 enters the brain, these cells shift into emergency defense mode. While this helps fight the virus, it may also compromise their ability to perform the everyday functions, even after the virus is gone.”
Chromatin Remodeling and Localized Vulnerability
Importantly, these phenotypic alterations were not distributed uniformly across the entire brain. Instead, they were tightly concentrated in discrete microenvironments where the virus was physically present, creating localized focal zones of heightened immune activation.
Further epigenetic analysis showed that HSV-1 exposure reorganized chromatin—the structural packaging of DNA inside the cell nucleus. By altering which sections of DNA remain open or closed to cellular transcription machinery, the virus altered the underlying molecular programming of the immune cells.
“What makes these findings particularly interesting is that the virus isn’t simply triggering inflammation,” noted Niemeyer. “It’s changing the molecular programs that control how these immune cells function. An important question is whether these changes persist after infection.”
The Shared Immune Signature of Neurodegeneration
The phenotypic shifts driven by HSV-1 bore a striking resemblance to microglial states documented in neurodegenerative pathology.
“Interestingly, the way that HSV-1 finely tunes the immune response in microglia resembles patterns found in response to other factors that drive Alzheimer’s disease,” explained co-senior author Kimberley Bruce, PhD, associate professor of medicine at CU Anschutz. “Although we have not established that HSV-1 causes Alzheimer’s, it highlights the immune programming of microglia as a common factor linking infection, aging and genetic risk factors.”
Alzheimer’s disease is recognized as a complex, multifactorial condition influenced by overlapping genetic predispositions, such as the APOE4 allele, and environmental exposures. By illustrating that a latent virus can rewire microglial chromatin, the study provides a mechanistic model for how repeated infections or subclinical viral reactivations across a lifetime could gradually exhaust microglial reserves, leaving brain circuits vulnerable to neurotoxic accumulation.
“Understanding how a common virus changes the brain’s immune environment may help us identify why some individuals become more vulnerable to neurodegeneration,” Niemeyer added.
The investigators are now preparing follow-up studies to determine whether these microglial chromatin alterations become permanent and how intermittent viral reactivations over decades influence long-term cognitive resilience.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this Alzheimer’s disease Research:
- Media Contact: David Kelly
- Source: University of Colorado
- Image Credit: Image credited to Neuroscience News
- Original Research is Open Access: PLOS Pathogens (Oct 1, 2026). “Intranasal HSV‑1 infection drives region‑specific interferon‑dominant microglial remodeling.” Authors: Seth Frietze, Cameron Lunn, Dean Oldham, Joseph R. Boyd, Andrew N. Bubak, Amalia Bustillos Saucedo, Maria A. Nagel, Diego Restrepo, Kimberley D. Bruce, and Christy S. Niemeyer.
- DOI: 10.1371/journal.ppat.1014684
Abstract
Herpes simplex virus type 1 (HSV-1) is a neurotropic pathogen capable of invading the central nervous system (CNS) and is associated with chronic neuroinflammation, cognitive impairment, and neurodegenerative disease. While microglia orchestrate the initial immune response to HSV‑1, the molecular mechanisms that regulate their sustained neuroinflammatory activity in vivo remain poorly understood.
To define the transcriptional and epigenetic mechanisms that shape microglial responses during acute HSV-1 infection in vivo, we have, for the first time, integrated single‑nucleus RNA sequencing, chromatin accessibility profiling, and spatial proteomics and transcriptomics in an intranasal HSV‑1 infection model.
Single-cell multiome analysis of CD11b⁺ nuclei identified transcriptionally and epigenetically distinct microglial and macrophage populations. HSV-1 infection redistributed monocyte-lineage states, with a marked overrepresentation of interferon (IFN)‑responsive microglia and macrophage-associated populations characterized by amplification of Stat1/2, Irf1, and Cebpb rather than reflecting uniform inflammatory activation. In parallel, homeostatic microglial gene signatures (e.g., ApoE, Cst3) were reduced following HSV-1 infection.
Spatial transcriptomics localized HSV‑1 antigen to discrete brainstem regions, which were enriched for predicted STAT1/2, IRF1, and CEBPB‑regulated targets identified through single‑nuclei analysis, demonstrating that these inferred transcriptional networks are activated within anatomically defined regions in vivo. Complementary spatial proteomics further confirmed increased microglial activation and astrocytic responses specifically within HSV-1 antigen-positive regions.
Together, these integrated multiomic analyses demonstrate that HSV-1 induces localized transcriptional and epigenetic remodeling of microglia dominated by IFN-driven regulatory programs and a loss of homeostatic signatures.
By linking single-cell regulatory architecture to spatially restricted tissue responses, our findings provide mechanistic insight into how localized viral infection sustains neuroinflammation, contributing to long-term neurological vulnerability and neurodegenerative disease risk.
